ArticleJournal of cancer research and clinical oncology2024

KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.

Meng Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.